Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

0.3% of mutual funds generated 100% of net flows for Q1

Monday, May 23, 2011
Opalesque Industry Update - In Q1/2011, according to a new research report by Strategic Insight, 0.3% of mutual funds around the world gathered over 100% of net flows for the quarter, totaling $210 billion in net cash contributions. This confirms a trend towards “blockbuster products and an accelerating winner-takes-all phenomenon in the global asset management industry since the financial crisis”, according to Daniel Enskat, Head of Global Consulting for Strategic Insight.

“In 2010, global net cash flows to long-term funds reached $850 billion. Of that total, a remarkable 95% of flows went to only 0.5% of products in the market, as asset holders around the world are reducing the number of managers they work with. In Q1/2011, the number was even higher: 0.3% of all products globally, i.e. 200 long-term funds, took in over 100% of flows, totaling $210 billion in net cash flows through March 2011,” added Enskat.

“Global financial institutions and distributors since the financial crisis in a back-to-basics environment are selecting fewer strategic partners and even fewer products. This mostly benefits large independent fund houses and, increasingly, selected investment boutiques.”

The report, ‘David and Goliath in the Global Asset Management Industry’, features case studies from the fastest growing boutiques around the world, e.g. Carmignac or Bluebay in Europe, Value Partners or Huashang in Asia, or Double Line or Pacific Heights in the US.

“Remarkably, the success stories are across asset classes, investment styles and categories”, added Enskat. “In addition to clear fund positioning/investment process and competitive performance – which a number of fund managers can demonstrate –, blockbuster firms in almost all cases have highly visible fund managers, outstanding marketing and proactive communication.”

For more information on this report, please visit: release Source
KM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for